摘要
目的:探讨康莱特的抗肿瘤机制,特别是凋亡的作用机制。方法:应用形态学方法、流式细胞术、DNA凝胶电泳、AnnexinV标记等方法检测细胞凋亡的发生。应用RT-PCR检测凋亡相关基因Fas、bc1-2、c-myc表达的变化。结果:康莱特对人肺腺癌细胞A549和人早幼粒细胞性白血病细胞HL60的生长均有抑制作用,引起细胞死亡。康莱特对A549细胞诱导凋亡的反应并不明显,而对HL60细胞有明显的凋亡。在HL60凋亡过程中,凋亡相关基因Fas转录水平比用药前增强,c-myc和bc1-2含量无变化。结论:凋亡与坏死同为康莱特抑瘤的机制,但不同细胞系凋亡所发生的比例不同。提示不同肿瘤,其凋亡规律亦不同,为康莱特的临床应用提供了理论依据。
To study the anti-tumor effect of Kanglaite(KLT)and the mechanisms of its induction of apoptosis of cancer cells.Morphological study,DNA gel electrophoresis,flow cytome try and fluorescein labelled Annexin V were used to detect the apoptosis and RT-PCR was used to de-tect the apoptosis related changes of gene Fas,bcl-2and c-myc.Results:The result showed that KLT could inhibit the proliferation of both HL-60and A549cells;KLT could also induce apoptosis of HL-60cells in which Fas gene took place in the process,but KLT did not act significantly on A549cells.Conclusion:KLT induced apoptosis and necrosis of human cnacer cells is the key role for its killing action on cancer cells in the treatment of cancer.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2002年第12期869-873,共5页
Chinese Journal of Clinical Oncology
基金
国家重点基础研究发展规划(973计划)基金资助(编号:G19998051201)